• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个人透析能力(PDC)测试的临床应用:持续性非卧床腹膜透析(CAPD)患者腹膜功能的系列分析

Clinical application of the Personal Dialysis Capacity (PDC) test: serial analysis of peritoneal function in CAPD patients.

作者信息

Imai H, Satoh K, Ohtani H, Hamai K, Haseyama T, Komatsuda A, Miura A B

机构信息

Third Department of Internal Medicine, Akita University School of Medicine, Japan.

出版信息

Kidney Int. 1998 Aug;54(2):546-53. doi: 10.1046/j.1523-1755.1998.00010.x.

DOI:10.1046/j.1523-1755.1998.00010.x
PMID:9690222
Abstract

BACKGROUND

Peritoneal damage has been reported since the beginning of CAPD therapy.

METHODS

To clarify the change of peritoneal function in CAPD patients, we used the Personal Dialysis Capacity (PDC) test in 22 patients with 49 serial studies and 14 patients with single studies. The data were expressed at the condition of 2.5% (2.27 g/dl of glucose), four times at 2,000 ml/day.

RESULTS

In the mass analysis, the urea generation rate, creatinine generation rate, PNA/PCR, and water removal via the peritoneum (PD) were kept at the same level for almost eight years, and then gradually decreased. Urine volume and residual renal creatinine clearance (CCr) became zero at six years. On the other hand, PD CCr increased gradually with the time course of CAPD, and therefore the total CCr remained at the level of 6.0 ml/min even after six years. Weekly urea KT/V decreased gradually from almost 2.800 to 2.000. The protein loss remained approximately 7.0 g/day for the initial five years, then became 6.0 g/day, except in five patients who showed levels above 10.0 g/day on the first test of PDC. Weekly urea KT/V was correlated with residual renal CCr (P < 0.005), and significantly correlated with total CCr (weekly urea KT/V = -0.2798 + 0.3720 x total CCr; r = 0.915, P < 0.001). In the serial analysis, when the first and the last tests were compared, the urea generation rate increased significantly (mean +/- SD, 2.800 +/- 3.204 vs. 3.882 +/- 3.382; P < 0.0001); however, water removal via PD (1364 +/- 887 vs. 813 +/- 609; P = 0.021), total ultrafiltration (1762 +/- 841 vs. 1124 +/- 843; P = 0.042), and weekly urea KT/V (2.285 +/- 0.486 vs. 2.112 +/- 0.512; P = 0.026) decreased significantly. The delta water removal via PD/ duration became negative (-10.03 +/- 6.59 ml/week) in all 7 patients after more than four years, however, it was positive (+14.40 +/- 7.84 ml/week) in 6 of 10 patients after less than one year.

CONCLUSION

These results suggest that water removal via PD increases within one year, then decreases after four years. The PDC test is useful to evaluate the change of peritoneal function in mass and serial analyses.

摘要

背景

自持续性非卧床腹膜透析(CAPD)治疗开始以来,已有腹膜损伤的报道。

方法

为阐明CAPD患者腹膜功能的变化,我们对22例患者进行了49次连续研究,并对14例患者进行了单次研究,采用了个人透析能力(PDC)测试。数据以2.5%(葡萄糖2.27g/dl)、每天2000ml、四次交换的条件表示。

结果

在总体分析中,尿素生成率、肌酐生成率、蛋白氮呈现率/蛋白分解代谢率以及通过腹膜(PD)的水清除量在近八年保持在同一水平,然后逐渐下降。尿量和残余肾肌酐清除率(CCr)在六年时降为零。另一方面,PD CCr随CAPD的病程逐渐增加,因此即使在六年之后,总CCr仍保持在6.0ml/分钟的水平。每周尿素KT/V从近2.800逐渐降至2.000。最初五年蛋白丢失量约为每天7.0g,之后变为6.0g,但在5例患者中,其在PDC首次测试时蛋白丢失量高于10.0g/天。每周尿素KT/V与残余肾CCr相关(P<0.005),且与总CCr显著相关(每周尿素KT/V = -0.2798 + 0.3720×总CCr;r = 0.915,P<0.001)。在连续分析中,当比较首次和末次测试时,尿素生成率显著增加(平均值±标准差,2.800±3.204 vs. 3.882±3.382;P<0.0001);然而,通过PD的水清除量(1364±887 vs. 813±609;P = 0.021)、总超滤量(1762±841 vs. 1124±843;P = 0.042)以及每周尿素KT/V(2.285±0.486 vs. 2.112±0.512;P = 0.026)显著下降。四年后,所有7例患者通过PD的水清除量变化/时间均变为负值(-10.03±6.59ml/周),然而,在不到一年的时间里,10例患者中有6例为正值(+14.40±7.84ml/周)。

结论

这些结果表明,通过PD的水清除量在一年内增加,四年后减少。PDC测试有助于在总体和连续分析中评估腹膜功能的变化。

相似文献

1
Clinical application of the Personal Dialysis Capacity (PDC) test: serial analysis of peritoneal function in CAPD patients.个人透析能力(PDC)测试的临床应用:持续性非卧床腹膜透析(CAPD)患者腹膜功能的系列分析
Kidney Int. 1998 Aug;54(2):546-53. doi: 10.1046/j.1523-1755.1998.00010.x.
2
[The effect of the number of peritonitis episodes on peritoneal membrane function].[腹膜炎发作次数对腹膜功能的影响]
Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):28-31.
3
A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.PD ADEQUEST 2.0的多国临床验证研究。PD ADEQUEST国际研究小组。
Perit Dial Int. 1999 Nov-Dec;19(6):556-71.
4
Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.老年持续性非卧床腹膜透析患者血清白蛋白水平低归因于腹膜高通透性。
Adv Perit Dial. 2001;17:238-43.
5
Time dependence of solute removal during a single exchange.单次交换过程中溶质清除的时间依赖性。
Adv Perit Dial. 1997;13:23-8.
6
An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kinetics.对一组接受持续性非卧床腹膜透析超过3年的特定人群的透析充分性分析:尿素和肌酐动力学的影响
Nephrol Dial Transplant. 1993;8(11):1244-53.
7
Re-evaluation of adequate dose in Japanese peritoneal dialysis patients.
Adv Perit Dial. 2003;19:103-5.
8
Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.目标腹膜清除率所需的引流液量:基于腹膜转运类型和体型的公式
ASAIO J. 1998 Nov-Dec;44(6):828-34.
9
Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.腹膜透析患者腹膜转运率及透析充分性与炎症的关系。
Adv Perit Dial. 2006;22:2-6.
10
Comparison of long-term survival between hemodialysis and peritoneal dialysis.血液透析与腹膜透析的长期生存率比较。
Adv Perit Dial. 1996;12:79-88.

引用本文的文献

1
Longitudinal study of small solute transport and peritoneal protein clearance in peritoneal dialysis patients.腹透患者中小溶质转运和腹膜蛋白清除的纵向研究。
Clin J Am Soc Nephrol. 2014 Feb;9(2):326-34. doi: 10.2215/CJN.04420413. Epub 2013 Nov 21.